Unknown

Dataset Information

0

18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs.


ABSTRACT: Hepatic stellate cells (HSCs) are essential drivers of fibrogenesis. Inducing activated-HSC apoptosis is a promising strategy for treating hepatic fibrosis. 18beta-glycyrrhetinic acid (18β-GA) is a natural compound that exists widely in herbal medicines, such as Glycyrrhiza uralensis Fisch, which is used for treating multiple liver diseases, especially in Asia. In the present study, we demonstrated that 18β-GA decreased hepatic fibrosis by inducing the apoptosis in activated HSCs. 18β-GA inhibited the expression of α-smooth muscle actin and collagen type I alpha-1. Using a chemoproteomic approach derived from activity-based protein profiling, together with cellular thermal shift assay and surface plasmon resonance, we found that 18β-GA covalently targeted peroxiredoxin 1 (PRDX1) and peroxiredoxin 2 (PRDX2) proteins via binding to active cysteine residues and thereby inhibited their enzymatic activities. 18β-GA induced the elevation of reactive oxygen species (ROS), resulting in the apoptosis of activated HSCs. PRDX1 knockdown also led to ROS-mediated apoptosis in activated HSCs. Collectively, our findings revealed the target proteins and molecular mechanisms of 18β-GA in ameliorating hepatic fibrosis, highlighting the future development of 18β-GA as a novel therapeutic drug for hepatic fibrosis.

SUBMITTER: Zhang Q 

PROVIDER: S-EPMC9463498 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs.

Zhang Qian Q   Luo Piao P   Zheng Liuhai L   Chen Jiayun J   Zhang Junzhe J   Tang Huan H   Liu Dandan D   He Xueling X   Shi Qiaoli Q   Gu Liwei L   Li Jiahao J   Guo Qiuyan Q   Yang Chuanbin C   Wong Yin Kwan YK   Xia Fei F   Wang Jigang J  

Journal of pharmaceutical analysis 20220608 4


Hepatic stellate cells (HSCs) are essential drivers of fibrogenesis. Inducing activated-HSC apoptosis is a promising strategy for treating hepatic fibrosis. 18beta-glycyrrhetinic acid (18β-GA) is a natural compound that exists widely in herbal medicines, such as <i>Glycyrrhiza uralensis</i> Fisch, which is used for treating multiple liver diseases, especially in Asia. In the present study, we demonstrated that 18β-GA decreased hepatic fibrosis by inducing the apoptosis in activated HSCs. 18β-GA  ...[more]

Similar Datasets

| S-EPMC6378220 | biostudies-literature
| S-EPMC5041150 | biostudies-literature
| S-EPMC10509061 | biostudies-literature
| S-EPMC6170444 | biostudies-literature
| S-EPMC6433757 | biostudies-literature
| S-EPMC6984097 | biostudies-literature
| S-EPMC10909858 | biostudies-literature
| S-EPMC10786946 | biostudies-literature
| S-EPMC6008326 | biostudies-literature
| S-EPMC11352036 | biostudies-literature